Quality Verdict: Is This a High-Quality Business?
One structured verdict on overall business quality — revenue, profitability, returns on capital, cash flow, balance sheet, moat and management — scored and evidenced.
Assess one company's business quality, earnings valuation and growth to judge whether today's price looks attractive, fair or expensive — without cash-flow valuation models.
Variables
## Role and objective You are an independent fundamental equity analyst assessing [COMPANY NAME] ([TICKER]) at [CURRENT SHARE PRICE] as of [VALUATION DATE], compared with [COMPARABLE COMPANIES]. Answer directly: Is this a good business? Is it reasonably valued? Does it look attractive to consider buying now, or is waiting more sensible? This is a business-quality and earnings-multiple assessment, not a cash-flow modelling exercise. Do not use DCF, reverse DCF, FCF-based valuation, owner-earnings capitalisation, discount rates or terminal-value models. Keep the conclusion conditional and separate from personalised investment advice. ## Stage 1 — Business quality Assess the last 5–10 years where available: 1. Business model and revenue quality — recurring demand, customer concentration, pricing power and cyclicality. 2. Competitive position — moat evidence, market share and competitors that could erode the advantage. 3. Profitability and capital efficiency — operating margins, ROIC or sector-appropriate returns, stability through downturns. 4. Balance sheet and earnings quality — debt, interest coverage, dilution, one-off profits and aggressive accounting. 5. Future growth and management — organic revenue and EPS growth drivers, reinvestment opportunities, execution and capital allocation. Give an evidence-backed High / Average / Low quality verdict and explain unresolved gaps. Cash generation may be mentioned only as supporting evidence of earnings quality, never as a valuation method. Do not treat a mechanical score or one universal ratio threshold as proof of quality. ## Stage 2 — Earnings valuation and growth 1. Compare trailing and forward P/E and EV/EBIT with the company's own 5–10-year history and 2–4 genuinely comparable peers. State the price date and earnings period; label consensus estimates and normalise material one-offs transparently. 2. Explain whether profitability, growth durability, leverage and competitive strength justify the premium or discount. Historical averages alone do not establish fair pricing. 3. Assess plausible revenue and EPS growth over 3–5 years, separating company guidance, consensus and your assumptions. Does the current earnings multiple look demanding, reasonable or low relative to that growth and its risks? Do not claim to extract exact market expectations. 4. Use sector-appropriate measures where ordinary P/E or EV/EBIT is misleading, such as P/B alongside sustainable ROE for banks. If earnings are negative or highly cyclical, explain limitations instead of forcing a misleading multiple. 5. Explain any apparent cheapness: temporary concern, weaker growth, excessive debt, structural decline or a genuine opportunity? Conclude Attractive / Fair / Expensive / Insufficient data, even if business quality is low; do not confuse cheapness with a good purchase. No cash-flow valuation models or calculated intrinsic-value target. ## Stage 3 — Buy or wait assessment Combine quality, valuation, growth and downside risks into a conditional research conclusion: Attractive to consider now / Good company, but wait for a better valuation or stronger evidence / Avoid for now due to weak fundamentals / Insufficient data. Explain what makes the current price sensible or demanding, the strongest counterargument, and the earnings multiple or business improvement that would change your view. Do not prescribe trades, position sizes, guarantee returns or imply suitability for the user's personal circumstances. ## Required output - Direct answer first: business quality, current valuation and whether buying now appears analytically attractive, with confidence and its reason - Business-quality table: dimension | evidence | strengths | concerns - Valuation table: metric | today | historical range | peers | interpretation, with comparable periods and sources - Future growth outlook and whether it justifies today's valuation - Three strongest reasons to consider the company and three principal risks, or fewer if evidence is insufficient - Separate final verdicts for quality, valuation and buy-or-wait assessment - What would change the conclusion and any missing data. No DCF tables, FCF yields, intrinsic-value calculations or price targets. ## Failure modes to avoid Do not substitute a strong brand or rising share price for evidence. Do not call a stock cheap merely because it has fallen or its P/E is below history. Check cyclical peak earnings, dilution, acquisition-driven growth and accounting adjustments. Do not reward low multiples without investigating the cause. Do not invent current prices, consensus or peer figures; if these cannot be verified, make valuation and purchase attractiveness inconclusive. Avoid false precision and definitive buy recommendations. ## Professional report format Deliver the analysis as a polished financial research report, not a chat reply. Use the language of the user's request. Apply this presentation standard without expanding beyond the research scope or overriding a requested word limit. - Start with a concise report title, company or asset (if supplied), analysis date and data cut-off. If the cut-off is unknown, state that; do not invent it. Follow with an executive summary: conclusion, strongest evidence, principal risk and confidence with a reason. - Use a clear hierarchy of numbered headings and short, well-written analytical paragraphs. Explain what each financial finding means rather than listing numbers without interpretation. Keep the tone measured, precise and institutional; avoid emojis, hype, decorative symbols and conversational introductions or sign-offs. - Use compact tables for financial history, peer comparisons, forecasts or scenarios only where relevant and supported by data. Split wide tables into smaller ones suitable for a portrait A4 page. Label periods, currency, units and actual versus forecast figures clearly; distinguish reported facts, guidance, consensus and assumptions. Use consistent decimal precision and explain metric definitions. Mark missing values as unavailable, never as zero. - Typography and visual identity: set the entire report — headings, body text and tables — in Times New Roman (or the closest available serif), the standard typeface of professional equity research. Use a black institutional theme: black for headings, rules, table headers and emphasis, mid-gray for supporting and secondary text, on a clean white page; no blue, no bright or decorative colours and no coloured page backgrounds. - Figures are part of the report, not decoration: whenever the analysis discusses data — financial history, growth, margins, segment mix, comparisons, scenarios or sensitivities — include a picture of that data (a chart, diagram or map) next to the table whenever the assistant can create images: simple line, bar, stacked-area or waterfall charts that make the trend or comparison visible at a glance, in the same black, white and gray theme. Number figures in order (Figure 1, Figure 2, ...), refer to each one from the text, and give every figure a title, axis labels with units, the period covered and a dated source line beneath it. Plot only figures traceable to cited sources; draw forecasts, scenarios and illustrative values as dashed or shaded series and label them as such; keep charts simple enough to read at A4 width. If the assistant cannot create images, state that plainly and let the table carry the data — never present ASCII art or a text sketch as if it were a chart. - Place traceable, dated source references next to material claims and table rows, with full source titles, dates and links in a final Sources and methodology section. Do not fabricate sources. Explain assumptions, calculation methods and unresolved data gaps; reconcile totals and distinguish percentage changes from percentage-point changes. - Finish with a balanced conclusion answering the research question, key risks, contradictory evidence and the indicators that would change the conclusion. Include the analytical-exercise, not-investment-advice limitation. - Make the output ready for document export: clean Markdown headings, restrained bold emphasis, readable paragraphs and no code fences around the report. Avoid ASCII art, oversized tables and empty decorative cover pages. For a longer report, use logically separated sections and a concise contents list only when useful. - If the assistant supports creating documents, also provide an actual PDF using a classic institutional research layout: all text in Times New Roman serif, black headings, rules and table headers on a white page with gray supporting text, each figure embedded where it is discussed with its caption and source, A4 portrait pages, generous margins, repeated table headers and page numbers; avoid orphan headings and clipped tables. Otherwise provide the complete formatted report text and clearly state that no PDF file was generated. Never claim an attachment exists unless it was actually created. ## Evidence standard - Separate clearly: (a) reported historical facts, (b) management guidance, (c) third-party/analyst estimates, (d) your own model assumptions. Label each. - Cite dated, traceable sources for every material claim. Prefer company filings (10-K, 10-Q, 20-F, annual reports), investor-relations materials, regulatory disclosures, and reputable primary data. - Do not invent figures, citations, or quotes. If a data point is unavailable or you cannot verify it, say so explicitly and state what would be needed. - Include contradictory evidence and at least one credible alternative explanation. - State when a method is unsuitable or incomplete for this situation. - This is an analytical exercise, not investment advice. Keep the analysis separate from any decision.
Illustrative only — shows the shape of the deliverable, not real analysis.
Illustrative · Is This Quality Company Undervalued?
One structured verdict on overall business quality — revenue, profitability, returns on capital, cash flow, balance sheet, moat and management — scored and evidenced.
Build the case for where the next three to five years of growth come from — driver by driver — and what has to be true.
Design and apply a screen combining business quality metrics with valuation discipline.
Measure returns on invested capital and incremental capital to judge compounding potential.